These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27986283)

  • 1. Galectin-3 and atrial fibrillation.
    Duygu H
    Int J Cardiol; 2017 Feb; 229():1. PubMed ID: 27986283
    [No Abstract]   [Full Text] [Related]  

  • 2. Galectin-3: A potential new target for upstream therapy of atrial fibrillation.
    He B; Huang B; Lu Z; He W; Jiang H
    Int J Cardiol; 2016 Jan; 203():1131-2. PubMed ID: 26608016
    [No Abstract]   [Full Text] [Related]  

  • 3. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.
    Clementy N; Piver E; Bisson A; Andre C; Bernard A; Pierre B; Fauchier L; Babuty D
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3: A biochemical marker to detect paroxysmal atrial fibrillation?
    Selcoki Y; Aydin Hİ; Celik TH; Isleyen A; Erayman A; Demircelik MB; Demirin H; Kosus A; Eryonucu B
    Clin Invest Med; 2016 Dec; 39(6):27528. PubMed ID: 27917818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to the letter to editor: Galectin-3 and atrial fibrillation.
    Sverdlov AL; Ngo DT
    Int J Cardiol; 2017 Feb; 229():2. PubMed ID: 27956319
    [No Abstract]   [Full Text] [Related]  

  • 7. The Inflammatory Hypothesis of Atrial Fibrillation: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?
    Witt C; Kapa S
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):641-3. PubMed ID: 25845673
    [No Abstract]   [Full Text] [Related]  

  • 8. Galectin-3 in atrial fibrillation: Simple bystander, player or both?
    Lippi G; Cervellin G; Sanchis-Gomar F
    Clin Biochem; 2015 Aug; 48(12):818-22. PubMed ID: 25952321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New onset atrial fibrillation is associated with elevated galectin-3 levels.
    Chen D; Procter N; Goh V; Liu S; Chua SJ; Assadi-Khansari B; Stewart S; Horowitz JD; Sverdlov AL; Ngo DT
    Int J Cardiol; 2016 Nov; 223():48-49. PubMed ID: 27529590
    [No Abstract]   [Full Text] [Related]  

  • 10. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.
    Hernández-Romero D; Vílchez JA; Lahoz Á; Romero-Aniorte AI; Jover E; García-Alberola A; Jara-Rubio R; Martínez CM; Valdés M; Marín F
    Sci Rep; 2017 Jan; 7():40378. PubMed ID: 28079145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is epicardial adipose tissue an epiphenomenon or a new player in the pathophysiology of atrial fibrillation?
    Hatem SN
    Arch Cardiovasc Dis; 2014; 107(6-7):349-52. PubMed ID: 25027058
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers Associated with Atrial Fibrosis and Remodeling.
    Dilaveris P; Antoniou CK; Manolakou P; Tsiamis E; Gatzoulis K; Tousoulis D
    Curr Med Chem; 2019; 26(5):780-802. PubMed ID: 28925871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation.
    Nedios S; Seewöster T; Lip GH; Husser D; Hindricks G; Bollmann A; Kornej J
    Int J Cardiol; 2016 Jan; 203():621-3. PubMed ID: 26580343
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation.
    Jalife J
    Heart Fail Clin; 2016 Apr; 12(2):309-22. PubMed ID: 26968673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 in Atrial Fibrillation: A Novel Marker of Atrial Remodeling or Just Bystander?
    Kornej J; Schmidl J; Bollmann A
    Am J Cardiol; 2015 Jul; 116(1):163. PubMed ID: 25956621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atrial fibrillation as consequence and cause of structural changes of atria].
    Aparina OP; Chikhireva LN; Stukalova OV; Mironova NA; Kashtanova SIu; Ternovoĭ SK; Golitsyn SP
    Kardiologiia; 2014; 54(11):57-64. PubMed ID: 25902660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.
    Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J
    BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of persistent atrial fibrillation on serum galectin-3 levels.
    Gurses KM; Yalcin MU; Kocyigit D; Canpinar H; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Ozer N; Tokgozoglu L; Oto MA; Guc D; Aytemir K
    Am J Cardiol; 2015 Mar; 115(5):647-51. PubMed ID: 25604929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel upstream approaches to prevent atrial fibrillation perpetuation.
    Jalife J
    Cardiol Clin; 2014 Nov; 32(4):637-50. PubMed ID: 25443242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
    Liu T; Zhao H; Li J; Korantzopoulos P; Li G
    Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.